Can-Fite Biopharma (CANF) Q4 2024 Earnings

Nov 29Confirmed
Q1 2023
Q2 2024
Q3 2024
Q4 2024
-0.19
-0.13
-0.06
0

Details

Expected EPS
-0.000899
Actual EPS
-0.000899
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Can-Fite Biopharma⁩ (⁦CANF⁩) has reported earnings of ⁦-0.000899⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts